Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: margie who wrote (4707)	7/2/1998 5:48:00 PM
From: Steve Fancy	of 6136

Study: Immune Response and Agouron Drug Helps HIV Patients July 2, 1998 Dow Jones Newswires WASHINGTON -- Immune Response Corp. (IMNR) and Agouron Pharmaceuticals Inc. (AGPH) said treatments given to HIV patients performed better when accompanied by Remune, a drug being developed by the companies. The preliminary data on Remune were presented at the 12th World AIDS Conference in Geneva Thursday. The data, from a phase II study of 43 patients with HIV, the virus that causes AIDS, showed patients taking Remune had larger immune responses to HIV than those not taking the drug. Also, the Remune patients' virus load dropped below detection levels more frequently. -Otesa Middleton; 202-862-6654

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next